A new antiviral compound designed and synthesized by researchers at the University of Wisconsin–Madison’s School of Pharmacy is highly effective in mice against two types of devastating encephalitis viruses that are harmful to humans.
3 most recent stories to be displayed on the SoP homepage.
A new antiviral compound designed and synthesized by researchers at the University of Wisconsin–Madison’s School of Pharmacy is highly effective in mice against two types of devastating encephalitis viruses that are harmful to humans.
A team featuring School of Pharmacy alumni and faculty are recognized for their innovative telehealth antimicrobial stewardship program.
ASHP honors the Wisconsin Society of Pharmacy Students for video series showcasing the impact of pharmacists.
The winning paper by Professor Michelle Chui, alum Taylor Watterson (MS ’18, PhD ’22) and collaborators explores impactful changes to pharmacist and prescriber workflow.
New rural health scholarship honors School of Pharmacy alumnus and pharmacist Lyle Vandenberg In partnership with the American Medical Association Foundation (AMAF) and the Wisconsin Foundation and Alumni Association, Brian Vandenberg, Homeward general counsel and chief …
Commendation for UW–Madison health professions schools partnership in continuing education recognizes capacity to provide continuing education for the healthcare team and exceed the core standards The University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP), which …
Alum Charlie Lee (BS ’96) weighs in on how pharmacist-prescribed Paxlovid expands pharmacists’ impact on community health.
School of Pharmacy students win recognition for Operation Heart and Operation Immunization outreach, innovative conference event.
A recent study by Assistant Professor Quanyin Hu points toward a potential new approach for pushing the limits of immunotherapy, opening a door to more effective treatment of inoperable tumors and metastatic cancer.
Combined with the probiotics themselves, newly developed nanoparticle “backpacks” could significantly improve — and simplify — IBD treatments.